Search Results

Quetiapine hemifumarate 200 mg  | 97.63%

TargetMol

Quetiapine hemifumarate (ICI-204636), an atypical antipsychotic, is used in the treatment of bipolar I mania, schizophrenia, bipolar II depression, bipolar I depression.

More Information Supplier Page

Ozagrel 200 mg  | Purity Not Available

TargetMol

Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.

More Information Supplier Page

Ozagrel 25 mg  | Purity Not Available

TargetMol

Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.

More Information Supplier Page

Ambroxol hydrochloride 200 mg  | 99.55%

TargetMol

Ambroxol hydrochloride is a metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

More Information Supplier Page

Ambroxol hydrochloride 100 mg  | 99.55%

TargetMol

Ambroxol hydrochloride is a metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

More Information Supplier Page

Rabusertib 100 mg  | 99.40%

TargetMol

Rabusertib is an inhibitor of the cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiating activity. Rabusertib has been used in trials studying the treatment of Cancer, Solid Tumors, Advanced Cancer, Pancreatic Neoplasms, and Non-Small Cell Lung Cancer.

More Information Supplier Page